Novo Nordisk plans to lay off approximately 400 employees at its Bloomington, Indiana manufacturing facility, reducing the workforce from 1,800 to about 1,400, a 22% cut.12
The layoffs are scheduled to take effect at the beginning of May 2026.2356
The Bloomington site was acquired by Novo Nordisk as part of its $11 billion purchase of Catalent in December 2024; Catalent had previously cut over 400 jobs there in December 2022.12
Novo Nordisk describes the site as a critical part of its U.S. manufacturing network and will provide severance, outplacement assistance, and transition support to affected employees.3
Bloomington Mayor Kerry Thomson stated the city will support impacted workers with job opportunities and resources.23
Sources:
1. https://www.marketscreener.com/news/novo-nordisk-to-cut-400-jobs-at-catalent-facility-in-indiana-ce7e51dedf88f620
2. https://nationaltoday.com/us/in/bloomington-in/news/2026/03/31/novo-nordisk-to-cut-400-jobs-at-bloomington-indiana-site/
3. https://www.ipm.org/news/2026-03-31/novo-nordisk-to-lay-off-400-bloomington-employees
5. https://www.fiercepharma.com/manufacturing/novo-nordisk-cuts-hundreds-roles-troubled-bloomington-site
6. https://www.ibj.com/articles/novo-nordisk-to-cut-400-jobs-in-bloomington